Search

Gigi Georgiana Huang

Examiner (ID: 12753)

Most Active Art Unit
1613
Art Unit(s)
1618, 1627, 1629, 1609, 1612, 1613, 1617, 1621
Total Applications
781
Issued Applications
217
Pending Applications
66
Abandoned Applications
506

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10031011 [patent_doc_number] => 09072311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-07 [patent_title] => 'Absorption of fat-soluble nutrients' [patent_app_type] => utility [patent_app_number] => 10/530598 [patent_app_country] => US [patent_app_date] => 2004-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6399 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10530598 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530598
Absorption of fat-soluble nutrients Jun 20, 2004 Issued
Array ( [id] => 5034248 [patent_doc_number] => 20070098787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Composition for preventing and treating varicose veins of lower extremities' [patent_app_type] => utility [patent_app_number] => 10/561274 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5702 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20070098787.pdf [firstpage_image] =>[orig_patent_app_number] => 10561274 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/561274
Composition for preventing and treating varicose veins of lower extremities Jun 17, 2004 Abandoned
Array ( [id] => 5000372 [patent_doc_number] => 20070043006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis' [patent_app_type] => utility [patent_app_number] => 10/557133 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3682 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043006.pdf [firstpage_image] =>[orig_patent_app_number] => 10557133 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557133
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis Jun 13, 2004 Abandoned
Array ( [id] => 5827177 [patent_doc_number] => 20060062857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Method of producing eggshell powder' [patent_app_type] => utility [patent_app_number] => 10/535779 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5025 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20060062857.pdf [firstpage_image] =>[orig_patent_app_number] => 10535779 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/535779
Method of producing eggshell powder May 27, 2004 Issued
Array ( [id] => 5727615 [patent_doc_number] => 20060058376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Composition having autonomic nerve modulating activity and method of use thereof' [patent_app_type] => utility [patent_app_number] => 10/544490 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5643 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20060058376.pdf [firstpage_image] =>[orig_patent_app_number] => 10544490 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544490
Composition having autonomic nerve modulating activity and method of use thereof May 26, 2004 Abandoned
Array ( [id] => 5689079 [patent_doc_number] => 20060287394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Composition and method for treating macular disorders' [patent_app_type] => utility [patent_app_number] => 10/557170 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4725 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287394.pdf [firstpage_image] =>[orig_patent_app_number] => 10557170 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557170
Composition and method for treating macular disorders May 25, 2004 Abandoned
Array ( [id] => 7409640 [patent_doc_number] => 20040176290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration' [patent_app_type] => new [patent_app_number] => 10/484550 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10875 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176290.pdf [firstpage_image] =>[orig_patent_app_number] => 10484550 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/484550
Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration May 10, 2004 Abandoned
Array ( [id] => 7418753 [patent_doc_number] => 20040228820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Compositions comprising an amidine and an alkane polyol' [patent_app_type] => new [patent_app_number] => 10/841193 [patent_app_country] => US [patent_app_date] => 2004-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8233 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20040228820.pdf [firstpage_image] =>[orig_patent_app_number] => 10841193 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/841193
Compositions comprising an amidine and an alkane polyol May 6, 2004 Abandoned
Array ( [id] => 5667627 [patent_doc_number] => 20060172977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-03 [patent_title] => 'Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage' [patent_app_type] => utility [patent_app_number] => 10/549961 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4446 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20060172977.pdf [firstpage_image] =>[orig_patent_app_number] => 10549961 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/549961
Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage Apr 25, 2004 Abandoned
Array ( [id] => 7148311 [patent_doc_number] => 20040170666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Eye coverings' [patent_app_type] => new [patent_app_number] => 10/477645 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8357 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20040170666.pdf [firstpage_image] =>[orig_patent_app_number] => 10477645 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477645
Eye coverings Apr 21, 2004 Abandoned
Array ( [id] => 5041231 [patent_doc_number] => 20070093513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Agent for repairing corneal perception' [patent_app_type] => utility [patent_app_number] => 10/553320 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7041 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093513.pdf [firstpage_image] =>[orig_patent_app_number] => 10553320 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553320
Agent for repairing corneal perception Apr 15, 2004 Abandoned
Array ( [id] => 5786582 [patent_doc_number] => 20060205709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof' [patent_app_type] => utility [patent_app_number] => 10/553120 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30180 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205709.pdf [firstpage_image] =>[orig_patent_app_number] => 10553120 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/553120
Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof Apr 14, 2004 Abandoned
Array ( [id] => 5142465 [patent_doc_number] => 20070004681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-04 [patent_title] => 'Methods for treating arthritic conditions' [patent_app_type] => utility [patent_app_number] => 10/550532 [patent_app_country] => US [patent_app_date] => 2004-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10352 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20070004681.pdf [firstpage_image] =>[orig_patent_app_number] => 10550532 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/550532
Methods for treating arthritic conditions Mar 22, 2004 Abandoned
Array ( [id] => 5643366 [patent_doc_number] => 20060281821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Retinoid replacements and opsin agonists and methods for the use thereof' [patent_app_type] => utility [patent_app_number] => 10/548612 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 21564 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281821.pdf [firstpage_image] =>[orig_patent_app_number] => 10548612 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/548612
Retinoid replacements and opsin agonists and methods for the use thereof Mar 14, 2004 Abandoned
Array ( [id] => 7265168 [patent_doc_number] => 20040242704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Stabilized mutant opsin proteins' [patent_app_type] => new [patent_app_number] => 10/801078 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10945 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242704.pdf [firstpage_image] =>[orig_patent_app_number] => 10801078 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/801078
Stabilized mutant opsin proteins Mar 14, 2004 Abandoned
Array ( [id] => 7172563 [patent_doc_number] => 20050203086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Methods of treatment using an EP2 selective receptor agonist' [patent_app_type] => utility [patent_app_number] => 10/793530 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44445 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20050203086.pdf [firstpage_image] =>[orig_patent_app_number] => 10793530 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793530
Methods of treatment using an EP2 selective receptor agonist Mar 3, 2004 Abandoned
Array ( [id] => 7379048 [patent_doc_number] => 20040220270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-04 [patent_title] => 'Methods and composition of treating glaucoma by modulating tyrosinase/L-DOPA pathway' [patent_app_type] => new [patent_app_number] => 10/793604 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8942 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20040220270.pdf [firstpage_image] =>[orig_patent_app_number] => 10793604 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793604
Methods and composition of treating glaucoma by modulating tyrosinase/L-DOPA pathway Mar 3, 2004 Abandoned
Array ( [id] => 5022226 [patent_doc_number] => 20070148192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Stable ophthalmic composition' [patent_app_type] => utility [patent_app_number] => 10/546417 [patent_app_country] => US [patent_app_date] => 2004-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3417 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148192.pdf [firstpage_image] =>[orig_patent_app_number] => 10546417 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546417
Stable ophthalmic composition Feb 22, 2004 Abandoned
Array ( [id] => 7275155 [patent_doc_number] => 20040234606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Localized vaginal delivery without detrimental blood levels' [patent_app_type] => new [patent_app_number] => 10/778151 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7309 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234606.pdf [firstpage_image] =>[orig_patent_app_number] => 10778151 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/778151
Localized vaginal delivery without detrimental blood levels Feb 16, 2004 Abandoned
Array ( [id] => 5834302 [patent_doc_number] => 20060246132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Sustained release formulations of venlafaxine' [patent_app_type] => utility [patent_app_number] => 10/544624 [patent_app_country] => US [patent_app_date] => 2004-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3140 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246132.pdf [firstpage_image] =>[orig_patent_app_number] => 10544624 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/544624
Sustained release formulations of venlafaxine Feb 8, 2004 Abandoned
Menu